Cite
HARVARD Citation
Kim, J. et al. (n.d.). P427 Efficacy and safety of vedolizumab and adalimumab in Asian adults with moderately to severely active ulcerative colitis: Post-hoc analysis of the VARSITY trial. Journal of Crohn's and colitis. pp. S431-S432. [Online].